Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis
On the heels of its Genome Explorations acquisition, the company wants to create a biomarker panel to differentiate mild traumatic brain injury from PTSD.
Diagnostics Developer Early is Good Raises $4M in Seed Funding
The company will use the funds to complete clinical trials for its first product, BCDx, a laboratory-developed test for early bladder cancer detection.
MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.
Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
The company published a pilot study showing that it's five-miRNA signature could predict which lung cancer patients survived longer on immunotherapy treatment.
The EU-backed project, called Serena, envisions the deployment of a multisensor platform that can detect microRNAs and long noncoding RNAs associated with the disease.